BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AZD1043 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AZD1043\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07511205-11155@assetmemo.bio
DTSTAMP:20261121T005556Z
DTSTART;VALUE=DATE:20270409
DTEND;VALUE=DATE:20270410
SUMMARY:AZD1043: Phase 1 readout est. (NCT07511205)
DESCRIPTION:AZD1043\, phase 1\, Obesity.\nStudy: A Study to Investigate Saf
 ety\, Tolerability\, Pharmacokinetics and Pharmacodynamics of AZD1043 in H
 ealthy Adult Participants Living With Overweight and/or Obesity.\nEstimate
 d primary completion: 9 April 2027. This is a ClinicalTrials.gov estimate\
 , not a confirmed readout date\, and it can move.\nDrug page: https://asse
 tmemo.bio/drug/azd1043#upcoming-events\nRegistry record: https://clinicalt
 rials.gov/study/NCT07511205
URL:https://assetmemo.bio/drug/azd1043#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
